This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Harmonisation of fees
Last modified: 25 February 2025
BAREC has standardized certain fees that are not legally required. This helps optimize processes and ensures greater clarity. Regularly reviewing the updated rates is essential to ensure they stay aligned with rising costs and administrative demands.
Based on the feedback received from our members, the BAREC Board has decided on the following amounts:
1. Biobank Recognition:
The initial recognition fee and bi-annual reassessment fee is increased to €2000. This better aligns with the administrative costs and efforts involved in the biobank evaluation process and the required bi-annual report submission to the EC.
2. Retrospective Commercial Studies:
The initial fee for retrospective commercial studies is set at €656.76 (in 2025). This fee is based on the fee for a non-interventional experiment.
The amendment fee will be €164.21.
3. Commercial studies on secondary use of HBM (Human Body Material):
We refer to the above fees for retrospective studies when applying the same rates to commercial studies involving human biological material, ensuring consistency across different study types.
4. Non-Study Specific Recruitment Materials:
A €500 fee for reviewing non-study-specific recruitment materials is appropriate, covering the time and resources needed for evaluation.